Quantcast

Latest Bisphosphonates Stories

2011-11-21 16:05:00

The Rottenstein Law Group, which represents clients with claims of harm resulting from use of the drug Fosamax, notes with some regret a report that a âœnovel treatment known as whole-body vibration doesnât appear to improve the bone health of postmenopausal women who are at high risk of developing osteoporosis.â New York, NY (PRWEB) November 21, 2011 According to a November 15 piece published by U.S. News and World Report, the treatment,...

2011-11-07 10:00:00

The Rottenstein Law Group, which represents clients with claims of harm resulting from use of the drug Fosamax, is concerned that many with osteoporosis might not know it and therefore might not be getting necessary treatment timely, but maintains that those who are diagnosed with the condition should discuss with their physicians in detail the possible serious adverse side effects of bisphosphonate drugs. New York, NY (PRWEB) November 07, 2011 According to an October 31, 2011, New York...

2011-09-30 05:40:19

(Ivanhoe Newswire) -- A new study suggests adding zoledronic acid to a drug regimen for patients with early stage breast cancer does not improve outcome. Zoledronic acid is a bisphosphonate that is used to treat osteoporosis and prevent skeletal fractures in patients with some types of cancer. In previous studies, bisphosphonates were shown to prevent or delay cancer metastasis and even reduce rates of recurrence and death. Researchers randomly assigned 3,360 patients to receive...

2011-09-26 07:00:00

The Rottenstein Law Group, which represents clients with claims of harm resulting from use of the drug Fosamax, has commissioned and published an infographic to educate the public about the history and dangers of the medication. New York, NY (PRWEB) September 26, 2011 The Rottenstein Law Group, which represents clients with claims of harm resulting from use of the drug Fosamax, has commissioned and published an infographic to educate the public about the history and dangers of the...

2011-09-26 15:17:32

A drug used to protect bone may extend survival in older breast cancer patients, according to researchers at the Universities of Sheffield and Leeds. The AZURE trial, led by Professor Robert Coleman from the University of Sheffield, has revealed that the bisphosphonate drug zoledronic acid boosts disease-free survival in postmenopausal breast cancer patients but may have an adverse effect on younger women. The full results of the trial were presented today (25 September 2011) at the...

2011-09-19 19:30:00

The Rottenstein Law Group, which represents clients with claims of harm resulting from use of the drug Fosamax, is paying especial attention to the developments in the fifth case involving Fosamax and a painful condition known as osteonecrosis of the jaw to go to trial, now underway. New York, NY (PRWEB) September 19, 2011 On September 8, in Secrest v. Merckâ”a so-called bellwether lawsuit of the many that were consolidated for pre-trial purposes in In Re: Fosamax...

2011-09-06 07:00:00

The US Drug Watchdog is dramatically expanding its national initiative involving the osteoporosis drug called Fosamax, and women who may have suffered out of the blue fractures to their femur, or thigh bone. According to the FDA, "typically these fractures occurred after using Fosamax for five years, or more." The US Drug Watchdog says, "In the instance of Fosamax, we are talking about women, whose leg simply broke. They did not fall, they did not run into something, their femur bone simply...

2011-09-05 09:00:00

The Rottenstein Law Group, which represents clients with claims of harm resulting from use of the drug Fosamax, notes a recent possible setback for Canadians who have suffered harm after taking Fosamax. New York, NY (PRWEB) September 05, 2011 In early June 2011, the Quebec Superior Court dismissed a motion seeking authorization of a class action against Merck Canada Inc and Merck & Co Inc on behalf of all natural persons in Quebec who had purchased or taken Fosamax. The petitioner in...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.